EIF5A and ovarian carcinoma: EIF5A was found to be dysregulated in high-grade colon and in rectal carcinoma [26] and in several other tumour types, such as glioblastoma, cervical and ovarian cancer, bladder cancer and non-small-cell lung cancer [29].